INFECTION and Aspirin


INFECTION Symptoms and Causes

Having HIV/AIDS weakens your body's immune system. It destroys the white blood cells that fight Infection. This puts you at risk for opportunistic Infections (OIs). OIs are serious Infections that take advantage of your weak immune system. These Infections are less common and less severe in healthy people.

There are many types of OIs:

  • Bacterial Infections, including tuberculosis and a serious related disease, Mycobacterium avium complex (MAC)
  • Viral Infections, such as cytomegalovirus (CMV) and hepatitis C
  • Fungal Infections, like yeast Infections, cryptococcal meningitis, pneumocystis carinii pneumonia (PCP) and histoplasmosis
  • Parasitic Infections, such as crypto (cryptosporidiosis) and toxo (toxoplasmosis)

Having HIV/AIDS can make Infections harder to treat. People with HIV/AIDS are also more likely to have complications from common illnesses such as the flu.

You can help prevent Infections by taking your HIV/AIDS medicines. Other things that can help include practicing safe sex, washing your hands well and often, and cooking your food thoroughly.

Check out the latest treatments for INFECTION

INFECTION treatment research studies

Aspirin clinical trials, surveys and public health registries

Find Drug Side Effect reports

Aspirin Side Effects

Gastrointestinal Haemorrhage (587)
Anaemia (521)
Dyspnoea (435)
Flushing (399)
Dizziness (384)
Myocardial Infarction (354)
Nausea (352)
Melaena (340)
Asthenia (335)
Vomiting (324)
Haemoglobin Decreased (309)
Haematemesis (306)
Diarrhoea (302)
Chest Pain (295)
Pruritus (279)
Fall (266)
Haemorrhage (262)
Fatigue (256)
Headache (244)
Hypotension (243)
Angioedema (238)
Gastric Haemorrhage (231)
Rectal Haemorrhage (227)
Epistaxis (226)
Abdominal Pain Upper (223)
Cerebrovascular Accident (222)
Completed Suicide (221)
Abdominal Pain (218)
Gastric Ulcer (216)
Haematochezia (207)
Cerebral Haemorrhage (202)
Malaise (190)
Pain (188)
Paraesthesia (188)
Renal Failure Acute (187)
Rash (178)
Faeces Discoloured (175)
Loss Of Consciousness (171)
Contusion (169)
Pneumonia (167)
Pyrexia (165)
Syncope (164)
Death (161)
Atrial Fibrillation (158)
Confusional State (154)
Feeling Hot (154)
Oedema Peripheral (153)
Hypertension (151)
Duodenal Ulcer (149)
Thrombocytopenia (147)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)

Recent Reviews

14 month old girl developed erythematous skin lasion on left cheek 5 days post prevnar vaccine. 24 hrs later lesion weeping straw colored fluid and crusted. seen at pediatrician 7 days post prevnar vaccine and also diagnosed with ear infection. Start

Afte taking baby aspirin for awhile i felt and still hearing an sssss sound in the back of my head .

Can asprin cause tininitus if the daily dose is 100mg

Constant lower abdomen ,nausea,headaches,loss of appetite

Cual es o son los efectos secundarios derivados de tomar cardioaspirina?

Cuales son los lados secundarios, y si puedo obtener en londres mas baratos

Does cardio aspirin lower the thrombosis count in the blood?

Hand tremor

Heyy my urine is reddish colur and ive gt a throat infection

Hi few days ago i went to my gp with urine burning pain leftside of belly bit blood in urine and now i have small swelling to my belly near belly button it feels sore and hurts when i touch it can anyone out there plz help me

In Oct. 2010 I had a penile implant surgery. One month to the day it was removed because of infection. I have had 3 1/2 month that I wouldn't wish on anyone. It's now 4 months later and the Dr. tells me he wouldn't a

48 years of age. I was diagnosed with urinary tract infection. Had one dose of monuril 3 gr. After 7 hours developed skin rash on the back, arms and neck, generally swelling of the face, specially below the eyes, Had oral antihistamine and went to

I have an ear infection where my ear canal is covered in blisters and blood/fluid coming out, also mu ear is completely blocked. I am on antibiotics and drops but a friend mentioned that they took oflocet 200mg when had a similar problem, but I hav

I am sorry you are in pain. But did you not just say you have Pneumonia!? I think that life threatening infection is worse than the diarrhea dont you?

I have been taking ciprofloxacina for an stomacal infection. It has worked well, I feel much better but I have experienced dizziness (a lot of dizziness).

<b>Describe Your Pinaclor Experience Here:</b> was put on pinaclor for surgical wound infection at end of course got lumps on head

<span style='color: #808080;'><strong>I have an 11 yr old yorkie that has been on Clavamox 375 mgm for several cycles since end of April. He is also on FlortiFLora to avoid colon distress. His mouth infection has not g

<strong></strong><span style='color: #808080;'>id like to see more photos on the corneal leucoma patients inorder to appretiate the existence of such an eye infection...

<strong>My son who is 6 years old, had finished a whole round of a different antibiotic for sinus infection- he is up to 25 days of coughing. 4 days ago he was prescribed Biaxin. He has been vomiting -both ends - diarrhea- with severe rash all

1 Month ago I used garasone for ear infection and I have been experiencing balance problems like vertigo. I stoped taking it and I want to know if there is a cure for it.

INFECTION Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting CPP Bone Infection Registry
Conditions: Bone Infection;   Staphylococcus Aureus
Outcome Measures: Details on occurence and treatment of bone Infection;   Surgical approach, implants and technology;   Patient outcome;   Post-procedure complications and revisions
2 Recruiting Invasive Group A Streptococcus (GAS) Infection in Children: Bacterial Virulence Factors and Detection of Host Immunological and/or Genetic Factors of Predisposition to Infections
Condition: Invasive GAS Infection
Intervention: Genetic: DNA samples, GAS strains
Outcome Measures: virulence factors of GAS;   Assess the frequency and type of hereditary immune deficiency or Mendelian susceptibility to Infections associated with invasive GAS Infections in children without risk factors;   describe and compare the GAS emm genotypes and virulence factors with the profiles of strains isolated with invasive GAS Infection with known risk factors and with the profile of strains isolated with a non-invasive GAS Infections;   compare GAS emm genotypes and profiles of virulence strains responsible for invasive SGA Infections with strains causing noninvasive Infections
3 Recruiting Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection
Condition: Cytomegalovirus Congenital Infection
Intervention: Biological: standard intravenous immunoglobulin
Outcome Measures: Prevention of neurological damage due to Cytomegalovirus congenital Infection;   Evaluate safety of aspecific immunoglobulins in pregnant women with primary CMV Infection
4 Unknown  Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-Infection
Conditions: Latent Tuberculosis Infection;   HIV Infections;   Tuberculosis
Outcome Measures: Precise component(s) of T cell response against M.tuberculosis compromised by HIV Infection which leads to the development of severe forms of clinical tuberculosis.;   Elucidation of critical events of the cellular and molecular interactions that would be useful for developing newer therapeutic strategies and vaccination.
5 Recruiting Articulating Versus Static Antibiotic Loaded Spacers for the Treatment of Prosthetic Knee Infection
Conditions: Osteoarthritis;   Knee Infection;   Prosthetic Joint Infection;   Complications; Arthroplasty, Infection or Inflammation;   Complications; Arthroplasty
Interventions: Procedure: Static Spacer;   Procedure: Articulating Spacer
Outcome Measures: Range of motion;   Knee Society Score;   Operative time
6 Recruiting Ceftaroline in the Treatment of Bone and Joint Infections
Conditions: Osteomyelitis;   Joint Infections
Intervention: Drug: Ceftaroline
Outcome Measures: Sustained clinical remission from the treated osteoarticular Infection;   Initial clinical success from the treated osteoarticular Infection
7 Not yet recruiting Randomized Controlled Trial of Postoperative Infections Following Caesarean Section Infections Following Caesarean Section
Condition: Postoperative Infection
Intervention: Drug: Cefuroxime
Outcome Measures: Women: The incidence of post-CS Infection (endometritis, urinary tract Infections, and wound Infections);   Infant: admission to special care unit;   Women: length of the primary and any secondary hospitalization;   Women: readmissions to hospital/contact to the general practitioner on suspicion of Infection after Caesarean Section;   Women: antibiotic treatment on suspicion of Infection after Caesarean Section;   Infant: use of antifungal treatment against oral thrush;   Infant: necrotizing enterocolitis;   Infant: antibiotic treatment during hospital stay;   Infant: the need for intensive care treatment and length of stay in hospital;   Infant: Neonatal sepsis;   Women: Number of Participants with Adverse Events as a Measure of Safety and Tolerability
8 Unknown  Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial
Conditions: Hospital-Acquired Infection With Clostridium Difficile;   Hospital-Acquired VRE Infection or Colonization;   Hospital-Acquired MRSA Infection or Colonization
Intervention: Other: Admission to a novel hospital ward
Outcome Measures: Incidence of hospital-acquired Infection with Clostridium difficile, and hospital-acquired Infection or colonization with vancomycin-resistant Enterococcus (VRE), or methicillin-resistant Staphylococcus aureus (MRSA).;   Incidence of the same Infections in room-mates of study subjects. (i.e., event rates in non-study patients who have contact with infected study subjects).
9 Unknown  Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
Condition: Infection
Outcome Measures: Diagnostic value (sensitivity and sensibility, positive/negative predictive value) of F-18-FDG PET/CT imaging in the detection of CVCP Infection;   Diagnostic value (sensitivity and sensibility, positive/negative predictive value) of microcalorimetry in the detection of CVCP Infection
10 Recruiting Hospital Stay and Respiratory Infection
Condition: Respiratory Infection
Intervention: Other: Respiratory Infection
Outcome Measures: Strength in upper and lower limbs;   Quality of life;   Lung function;   Activity monitoring;   Quality of sleep;   Mood
11 Recruiting Detection and Characterization of Infections and Infection Susceptibility
Conditions: Immune Disorders;   Chronic Granulomatous Disease;   Genetic Immunological Deficiencies;   Hyperimmunoglobulin-E Recurrent Infection Syndrome;   Recurrent Infections
Outcome Measure: The primary endpoint of this study will be determination of a discretediagnosis of an infecting agent, an underlying susceptibility trait, or both.
12 Not yet recruiting Optimizing Prevention of Healthcare-Acquired Infections After Cardiac Surgery (HAI)_2
Conditions: Cardiovascular Disease;   Healthcare Associated Infectious Disease;   Sternal Superficial Wound Infection;   Deep Sternal Infection;   Mediastinitis;   Thoracotomy;   Conduit Harvest or Cannulation Site;   Sepsis;   Pneumonia
Intervention: Other: There is no intervention. The investigators are interviewing cardiac surgery staff with knowledge of Infection prevention.
Outcome Measure: Preventive Strategies
13 Recruiting Host Factors in Invasive and Recurrent Staphylococcus Aureus Infection
Conditions: Staphylococcal Aureus Infection;   Recurrent Staphylococcal Infection;   Invasive Staphylococcal Infection
Outcome Measure:
14 Recruiting Incisional Negative Pressure Wound Therapy for Prevention of Postoperative Infections Following Caesarean Section
Conditions: Surgical Wound Infection;   Infection; Cesarean Section;   Cesarean Section; Dehiscence;   Complications; Cesarean Section;   Complications; Cesarean Section, Wound, Dehiscence;   Wound; Rupture, Surgery, Cesarean Section
Interventions: Device: PICO from Smith&Nephew;   Other: Standard postoperative wound dressing
Outcome Measures: The incidence of post-CS wound Infection in each study group;   Length of the primary and any secondary hospitalization;   Readmissions to hospital/contact to the general practitioner on suspicion of Infection following Caesarean Section;   Number of Participants with a decreased health-related quality of life score as a measure of satisfaction and tolerability;   Antibiotic treatment on suspicion of Infection after Caesarean Section;   The cosmetic outcome as a measure of satisfaction
15 Recruiting The Amputation Surgical Site Infection Trial (ASSIT)
Conditions: Wound Infection;   Amputation Wound
Interventions: Drug: Co-amoxiclav;   Drug: Iodine;   Drug: Metronidazole;   Drug: Chlorhexidine;   Drug: Teicoplanin;   Drug: Clindamycin
Outcome Measures: Surgical Site Infection;   Impact of different skin preparations on Infection rates;   Rate of re-intervention;   Mortality;   Satisfactory healing rates;   Quality of life;   Resource use;   • Rate of C. Diff., MSSA (Methicillin Sensitive Staphylococcus Aureus), MRSA (Methicillin Resistant Staphylococcus Aureus) Infection;   Mobility;   Pain Control
16 Recruiting Study of Antibiotic Spacer Design to Treat Infection After Hip Replacement
Conditions: Osteoarthritis;   Hip Infection;   Prosthetic Joint Infection;   Complications; Arthroplasty, Infection or Inflammation;   Complications; Arthroplasty
Interventions: Procedure: Implantation of a static, non-articulating cement spacer.;   Procedure: Implantation of an articulating spacer.
Outcome Measures: Harris Hip Score;   Operative time;   Hip dislocation rates
17 Not yet recruiting Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
Condition: Human Hookworm Infection
Intervention: Biological: Necator americanus Human Hookworm Larvae
Outcome Measures: Study product-related adverse events;   Fecal egg counts;   Number of adult hookworms in feces post-treatment
18 Recruiting Contribution of Real Time Analyses of CARdio-RESpiratory Signals to the Diagnosis of Infection in PREterM Infants
Condition: Bacterial Infection
Intervention: Procedure: Analysis of the heart rate and respiratory characteristics / Telemonitoring system prototype developed by INSERM U-642
Outcome Measures: Diagnosis of proven or suspected bacterial Infection;   Inflammation without proven or suspected bacterial Infection defined as follows: a 6 hours period with CRP> 5 mg/L not classified as proven or suspected bacterial Infection.;   Periods of discomfort defined as at least two EDIN scores above 3 in a 6 hours period
19 Recruiting Antibiotics and Gut Microbiota Among Newborn Infants
Conditions: Surgical Wound Infection;   Infection; Cesarean Section;   Complications; Cesarean Section
Intervention: Drug: Cefuroxime
Outcome Measures: Maternal: incidence of post-CS Infection (endometritis, urinary tract Infections and wound Infection) in each study group;   Infant: fecal microbiota at the tenth day of life;   Maternal: Length of hospitalization;   Maternal: readmissions to hospital on suspicion of postpartum Infection following cesarean section;   Antibiotic treatment;   Infant: concentration of cefuroxime in blood samples;   Infant: immunological analyses in blood samples on day 3
20 Recruiting Dilute Betadine Lavage in the Prevention of Postoperative Infection
Conditions: Prosthesis-Related Infections;   Arthroplasty
Interventions: Procedure: Betadine Lavage;   Procedure: Saline Lavage
Outcome Measure: Infection Rate